World's Best Scientists 2026 revealed!
Eiichi Araki

Eiichi Araki

D-Index & Metrics

Medicine

D-Index
76
Citations
31099
World Ranking
18637
National Ranking
598

Overview

Eiichi Araki is a researcher affiliated with Kumamoto University in Japan. Their work primarily focuses on medicine, with significant contributions in biochemistry, genetics, and molecular biology. The key subfields of study include endocrinology, diabetes and metabolism, molecular biology, surgery, physiology, and epidemiology.

Their research topics encompass various aspects of diabetes and related metabolic conditions, including:

  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Diabetes Management and Research
  • Pancreatic Function and Diabetes
  • Adipose Tissue and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health

Frequent publication venues for Eiichi Araki include:

  • Journal of Diabetes Investigation
  • Journal of Atherosclerosis and Thrombosis
  • Diabetes
  • Diabetology International
  • Diabetes Obesity and Metabolism

They have collaborated extensively with several coauthors, indicating a strong network of research partnerships. Frequent coauthors are:

  • Tatsuya Kondo
  • Takeshi Matsumura
  • Hiroyuki Motoshima
  • Masaji Sakaguchi
  • Motoyuki Igata

Among Eiichi Araki's recent publications are:

  • Japanese Clinical Practice Guideline for Diabetes 2019, 2020, Diabetology International
  • Japanese Clinical Practice Guideline for Diabetes 2019, 2020, Journal of Diabetes Investigation
  • Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT -2 study): 52-week results from a randomized controlled trial, 2020, Diabetes Obesity and Metabolism
  • Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan, 2021, Journal of Gastroenterology
  • Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials, 2021, Cardiovascular Diabetology

Best Publications

  • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

    Yasuo Ohkubo;Hideki Kishikawa;Eiichi Araki;Takao Miyata

  • Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

    Yutaka Seino;Kishio Nanjo;Naoko Tajima;Takashi Kadowaki

  • Targeted disruption of the Chop gene delays endoplasmic reticulum stress–mediated diabetes

    Seiichi Oyadomari;Akio Koizumi;Kiyoshi Takeda;Tomomi Gotoh

  • International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values.

    Atsunori Kashiwagi;Masato Kasuga;Eiichi Araki;Yoshitomo Oka

  • Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake

    Naoto Kubota;Wataru Yano;Tetsuya Kubota;Tetsuya Kubota;Toshimasa Yamauchi

  • Report of the Committee on the classification and diagnostic criteria of diabetes mellitus : The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus

    Yutaka Seino;Kishio Nanjo;Naoko Tajima;Takashi Kadowaki

  • Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway

    Seiichi Oyadomari;Kiyoshi Takeda;Masaki Takiguchi;Tomomi Gotoh

  • Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells

    Daisuke Kukidome;Takeshi Nishikawa;Kazuhiro Sonoda;Koujiro Imoto

  • AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer

    Hiroyuki Motoshima;Barry J. Goldstein;Motoyuki Igata;Eiichi Araki

  • Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice

    Costantino Iadecola;Kiyoshi Niwa;Shigeru Nogawa;Xueren Zhao

  • Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications.

    Takeshi Nishikawa;Eiichi Araki

  • Reactive Oxygen Species from Mitochondria Induce Cyclooxygenase-2 Gene Expression in Human Mesangial Cells: Potential Role in Diabetic Nephropathy

    Shinsuke Kiritoshi;Takeshi Nishikawa;Kazuhiro Sonoda;Daisuke Kukidome

  • Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells

    Koji Sakai;Kazuya Matsumoto;Takeshi Nishikawa;Mihoshi Suefuji

  • Japanese Clinical Practice Guideline for Diabetes 2019

    Eiichi Araki;Atsushi Goto;Tatsuya Kondo;Mitsuhiko Noda

  • Japanese Clinical Practice Guideline for Diabetes 2016

    Masakazu Haneda;Mitsuhiko Noda;Hideki Origasa;Hiroshi Noto

  • Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

    Motoyuki Igata;Hiroyuki Motoshima;Kaku Tsuruzoe;Kanou Kojima

  • Statins Activate Peroxisome Proliferator-Activated Receptor γ Through Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase-Dependent Cyclooxygenase-2 Expression in Macrophages

    Miyuki Yano;Takeshi Matsumura;Takafumi Senokuchi;Norio Ishii

  • Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.

    Helena W. Rodbard;Ildiko Lingvay;John Reed;Raymond De La Rosa

  • Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

    Kohjiro Ueki;Takayoshi Sasako;Yukiko Okazaki;Masayuki Kato

  • Impact of Endoplasmic Reticulum Stress Pathway on Pancreatic β-Cells and Diabetes Mellitus

    Eiichi Araki;Seiichi Oyadomari;Masataka Mori

Frequent Co-Authors

Shizuya Yamashita
Shizuya Yamashita Osaka University
Shun Ishibashi
Shun Ishibashi Jichi Medical University
Hidenori Arai
Hidenori Arai Kyoto University
Hirotaka Watada
Hirotaka Watada Juntendo University
Nobuya Inagaki
Nobuya Inagaki Kyoto University
Takashi Kadowaki
Takashi Kadowaki Toranomon Hospital
Kohjiro Ueki
Kohjiro Ueki National Center For Global Health and Medicine
Yasuo Terauchi
Yasuo Terauchi Yokohama City University
Kazuyuki Tobe
Kazuyuki Tobe University of Toyama

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but considering alternative or complementary options, there are a variety of online degrees that can lead to rewarding careers in the healthcare sector. Areas such as medical billing and coding, nursing, healthcare administration, and advanced nursing roles are all accessible online and often offer flexible pathways.

Those looking for affordability can explore online medical coding classes with financial aid, making entry into vital non-clinical roles more accessible. Aspiring nurses who want to bypass traditional entrance exams may consider nursing schools that don't require teas test, simplifying the admissions process.

For those aiming for leadership, the best online healthcare administration degree programs prepare graduates for management roles within medical organizations. Registered nurses (RNs) looking to advance can take advantage of rn to np programs online, paving the way toward becoming a nurse practitioner.

Exploring these online degrees can help broaden your healthcare career opportunities and provide the flexibility to balance study with work or personal commitments.

Best Scientists Citing Eiichi Araki

Trending Scientists

Recently Published Articles